Shares of SenesTech Inc (NASDAQ:SNES) have been given a consensus broker rating score of 1.00 (Strong Buy) from the one analysts that cover the company, Zacks Investment Research reports. One analyst has rated the stock with a strong buy rating.
Analysts have set a 12-month consensus target price of $9.38 for the company and are anticipating that the company will post ($0.19) EPS for the current quarter, according to Zacks. Zacks has also assigned SenesTech an industry rank of 168 out of 265 based on the ratings given to related companies.
A number of research analysts have recently commented on the stock. ValuEngine raised shares of SenesTech from a “strong sell” rating to a “sell” rating in a research report on Friday, February 2nd. Craig Hallum set a $3.00 price objective on shares of SenesTech and gave the company a “buy” rating in a research report on Wednesday, November 22nd. Zacks Investment Research downgraded shares of SenesTech from a “hold” rating to a “sell” rating in a research report on Friday, January 5th. Finally, Roth Capital decreased their price objective on shares of SenesTech from $3.75 to $14.00 and set a “buy” rating for the company in a research report on Thursday, December 28th.
Several institutional investors and hedge funds have recently made changes to their positions in SNES. Skylands Capital LLC grew its position in shares of SenesTech by 140.1% in the 4th quarter. Skylands Capital LLC now owns 210,017 shares of the company’s stock valued at $151,000 after acquiring an additional 122,534 shares during the period. Sabby Management LLC bought a new position in shares of SenesTech in the 4th quarter valued at about $315,000. TCI Wealth Advisors Inc. bought a new position in shares of SenesTech in the 3rd quarter valued at about $748,000. Finally, Gilder Gagnon Howe & Co. LLC grew its position in shares of SenesTech by 32.1% in the 4th quarter. Gilder Gagnon Howe & Co. LLC now owns 1,424,173 shares of the company’s stock valued at $1,025,000 after acquiring an additional 345,674 shares during the period. 16.14% of the stock is owned by institutional investors.
Shares of SenesTech (NASDAQ:SNES) opened at $0.67 on Tuesday. The company has a debt-to-equity ratio of 0.17, a current ratio of 2.94 and a quick ratio of 2.67. SenesTech has a 52 week low of $0.56 and a 52 week high of $9.60. The stock has a market cap of $10.58 and a price-to-earnings ratio of -0.50.
SenesTech Company Profile
SenesTech, Inc is a United States-based biotechnology platform and research company. The Company is engaged in developing a technology for managing animal populations by fertility control. It offers ContraPest, a fertility control product candidate. ContraPest’s technology and approach targets the reproductive capabilities of both sexes.
For more information about research offerings from Zacks Investment Research, visit Zacks.com
Receive News & Ratings for SenesTech Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for SenesTech and related companies with MarketBeat.com's FREE daily email newsletter.